An artificial intelligence model from the Mayo Clinic detected abnormalities on scans up to two years before patients were ...
In people with Type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, ...
Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, ...
The U.S. Food and Drug Administration has authorized the granting of early access before regulatory approval to Revolution ...
Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of ...
The U.S. Food and Drug Administration has authorized Revolution Medicines ’ pill daraxonrasib for early access to patients with previously treated pancreatic ca ...
Diabetes mellitus affects more than 500 million people worldwide, and both Type 1 (T1D) and Type 2 (T2D) forms converge on a common endpoint: the loss or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results